{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:39:44Z","timestamp":1792521584388,"version":"4.5.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>\n                    Melanoma progression is generally associated with a stepwise increase in genomic complexity. Although the copy number variations (CNVs) known to occur in melanoma are well characterized, the order in which they accumulate during melanomagenesis remains incompletely understood. To explore this, we used droplet digital polymerase chain reaction to calculate absolute copy numbers of\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    , the most commonly amplified and deleted genes in melanoma, in 51 formalin-fixed, paraffin-embedded melanomas. Each sample also underwent chromosomal microarray analysis to determine its CNV burden, which we graded according to the number of the following melanoma-associated CNVs present:\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    gain,\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss,\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    gain, and\n                    <jats:italic toggle=\"yes\">MYB<\/jats:italic>\n                    loss. In this pilot study, increasing CNV burden was associated with a gradual increase in average\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    copy number: from 2.00 in CNV-negative melanomas to 2.68 in melanomas with isolated\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    gain; 2.75 in melanomas with\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    gain and\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss; 2.93 in melanomas with\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    gain and\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    gain; and 3.23 in melanomas with\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    gain,\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss, and\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    gain (\n                    <jats:italic toggle=\"yes\">F<\/jats:italic>\n                    = 10.43,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001). A parallel trend was observed for average\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    copy number, which decreased progressively with increasing CNV burden: from 2.02 in CNV-negative melanomas to 1.33 in melanomas with isolated\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss; 1.15 in melanomas with\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss and\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    gain; and 0.53 in melanomas with\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss and\n                    <jats:italic toggle=\"yes\">MYB<\/jats:italic>\n                    loss (\n                    <jats:italic toggle=\"yes\">F<\/jats:italic>\n                    = 12.01,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001). These findings support a potential model of stepwise CNV accumulation in melanoma: early\n                    <jats:italic toggle=\"yes\">RREB1<\/jats:italic>\n                    gain and\/or\n                    <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic>\n                    loss, followed by\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    gain, and ultimately\n                    <jats:italic toggle=\"yes\">MYB<\/jats:italic>\n                    loss.\n                  <\/jats:p>","DOI":"10.1097\/dad.0000000000003350","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:00:34Z","timestamp":1782457234000},"page":"853-859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-5768","authenticated-orcid":false,"given":"Jason R.","family":"McFadden","sequence":"first","affiliation":[{"name":"Yale School of Medicine, New Haven, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkar","family":"Htoo","sequence":"additional","affiliation":[{"name":"Albany Medical Center, Department of Pathology & Laboratory Medicine, Albany, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advaita S.","family":"Chaudhari","sequence":"additional","affiliation":[{"name":"Dartmouth College, Department of Biological Sciences, Hanover, NH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Stevanovic","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Tsongalis","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH; and"},{"name":"Dartmouth Health, Department of Pathology & Laboratory Medicine, Lebanon, NH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward G.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Dartmouth Health, Department of Pathology & Laboratory Medicine, Lebanon, NH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravindhan","family":"Sriharan","sequence":"additional","affiliation":[{"name":"Geisel School of Medicine at Dartmouth, Hanover, NH; and"},{"name":"Dartmouth Health, Department of Pathology & Laboratory Medicine, Lebanon, NH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"R1-20261020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R2-20261020","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/pcmr.12228","article-title":"Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK 4\/6 inhibitor PD 0332991 in melanoma cell lines","volume":"27","author":"Young","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"R3-20261020","first-page":"5669","article-title":"Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade","volume":"63","author":"Collisson","year":"2003","journal-title":"Cancer Res"},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PPO.0b013e31824d448c","article-title":"The role of the PI3K-AKT pathway in melanoma","volume":"18","author":"Davies","year":"2012","journal-title":"Cancer J"},{"key":"R5-20261020","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11912-018-0733-7","article-title":"Molecular pathways in melanomagenesis: what we learned from next-generation sequencing approaches","volume":"20","author":"Palmieri","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5858\/arpa.2024-0027-OA","article-title":"A droplet digital polymerase chain reaction-based tool to aid in melanoma diagnosis: development of a 4-Gene panel using 164 melanocytic neoplasms","volume":"149","author":"McFadden","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.pathol.2017.08.006","article-title":"Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases","volume":"49","author":"Su","year":"2017","journal-title":"Pathology"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:00:13Z","timestamp":1792519213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003350","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}